NCT04790877

Brief Summary

The overall objective of this study is to explore the glycemic index and glycemic load induced by an alcohol-free beer with modified composition (including almost full fermentation of carbohydrates and the addition of isomaltulose and a resistant maltodextrin), as well as its postprandial metabolic response, compared to the effect induced by: a) an alcohol-free beer with a usual composition; b) an alcohol-free beer with modified composition (including almost full fermentation of carbohydrates and the addition of a resistant maltodextrin). This study includes two cross-over sub-studies recruiting healthy participants. In the first one, 10 healthy volunteers receive 25 g of carbohydrates coming from: regular alcohol-free beer (RB), alcohol-free beer with almost completely eliminated maltose and enriched with isomaltulose (2.5 g/100 mL) and a resistant maltodextrin (0.8 g/100 mL) (IMB), alcohol-free beer with the same maltose removal enriched with resistant maltodextrin (2.0 g/100 mL) (MB) and glucose solution. In the second study, 20 healthy volunteers are provided with 50 g of carbohydrates from white bread and water and the same meal plus 14.3 g of carbohydrates coming from: RB, IMB, MB and extra white bread. Blood is sampled at baseline and for 2 h, every 15 min, after ingestion.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2020

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2020

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

March 2, 2021

Completed
8 days until next milestone

First Posted

Study publicly available on registry

March 10, 2021

Completed
20 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 30, 2021

Completed
Last Updated

September 30, 2021

Status Verified

September 1, 2021

Enrollment Period

11 months

First QC Date

March 2, 2021

Last Update Submit

September 29, 2021

Conditions

Keywords

CarbohydratesAlcohol-free beerMaltodextrinIsomaltulose

Outcome Measures

Primary Outcomes (32)

  • Glucose

    Change from Baseline to 15-minutes after consumption of the beverage.

  • Glucose

    Change from Baseline to 30-minutes after consumption of the beverage.

  • Glucose

    Change from Baseline to 45-minutes after consumption of the beverage.

  • Glucose

    Change from Baseline to 60-minutes after consumption of the beverage.

  • Glucose

    Change from Baseline to 75-minutes after consumption of the beverage.

  • Glucose

    Change from Baseline to 90-minutes after consumption of the beverage.

  • Glucose

    Change from Baseline to 105-minutes after consumption of the beverage.

  • Glucose

    Change from Baseline to 120-minutes after consumption of the beverage.

  • Insulin

    Change from Baseline to 15-minutes after consumption of the beverage.

  • Insulin

    Change from Baseline to 30-minutes after consumption of the beverage.

  • Insulin

    Change from Baseline to 45-minutes after consumption of the beverage.

  • Insulin

    Change from Baseline to 60-minutes after consumption of the beverage.

  • Insulin

    Change from Baseline to 75-minutes after consumption of the beverage.

  • Insulin

    Change from Baseline to 90-minutes after consumption of the beverage.

  • Insulin

    Change from Baseline to 105-minutes after consumption of the beverage.

  • Insulin

    Change from Baseline to 120-minutes after consumption of the beverage.

  • GLP-1

    Change from Baseline to 15-minutes after consumption of the beverage.

  • GLP-1

    Change from Baseline to 30-minutes after consumption of the beverage.

  • GLP-1

    Change from Baseline to 45-minutes after consumption of the beverage.

  • GLP-1

    Change from Baseline to 60-minutes after consumption of the beverage.

  • GLP-1

    Change from Baseline to 75-minutes after consumption of the beverage.

  • GLP-1

    Change from Baseline to 90-minutes after consumption of the beverage.

  • GLP-1

    Change from Baseline to 105-minutes after consumption of the beverage.

  • GLP-1

    Change from Baseline to 120-minutes after consumption of the beverage.

  • GIP

    Change from Baseline to 15-minutes after consumption of the beverage.

  • GIP

    Change from Baseline to 30-minutes after consumption of the beverage.

  • GIP

    Change from Baseline to 45-minutes after consumption of the beverage.

  • GIP

    Change from Baseline to 60-minutes after consumption of the beverage.

  • GIP

    Change from Baseline to 75-minutes after consumption of the beverage.

  • GIP

    Change from Baseline to 90-minutes after consumption of the beverage.

  • GIP

    Change from Baseline to 105-minutes after consumption of the beverage.

  • GIP

    Change from Baseline to 120-minutes after consumption of the beverage.

Secondary Outcomes (16)

  • Leptin

    Change from Baseline to 60-minutes after consumption of the beverage.

  • Leptin

    Change from Baseline to 120-minutes after consumption of the beverage.

  • Glucagon

    Change from Baseline to 60-minutes after consumption of the beverage.

  • Glucagon

    Change from Baseline to 120-minutes after consumption of the beverage.

  • Ghrelin

    Change from Baseline to 60-minutes after consumption of the beverage.

  • +11 more secondary outcomes

Study Arms (9)

First sub-study: Glucose beverage

ACTIVE COMPARATOR

This intervention entails the intake of a beverage including 25 g of glucose.

Other: Sub-study 1

First sub-study: Regular alcohol-free beer

EXPERIMENTAL

This intervention entails the intake of regular alcohol-free beer including 25 of carbohydrates.

Other: Sub-study 1

First sub-study: Alcohol-free beer with modified composition (isomaltulose + maltodextrin)

EXPERIMENTAL

This intervention entails the intake of an alcohol-free beer with modified composition in which the maltose has been almost completely eliminated and enriched with isomaltulose (2.5 g/100 mL) and a resistant maltodextrin (0.8 g/100 mL) (IMB). This beverage included 25 g of carbohydrates.

Other: Sub-study 1

First sub-study: Alcohol-free beer with modified composition (++ maltodextrin)

EXPERIMENTAL

This intervention entails the intake of an alcohol-free beer with modified composition in which the maltose has been almost completely eliminated and enriched with a resistant maltodextrin (2.0 g/100 mL) (MB). This beverage included 25 g of carbohydrates.

Other: Sub-study 1

Second sub-study: White bread + Water

ACTIVE COMPARATOR

This intervention entails the intake of white bread (providing 50 g of carbohydrates) and water.

Other: Sub-study 2

Second sub-study: White bread + Regular alcohol-free beer

EXPERIMENTAL

This intervention entails the intake of white bread (providing 50 g of carbohydrates) and regular alcohol-free beer (providing 14.3 g of carbohydrates).

Other: Sub-study 2

Second sub-study: White bread+Alcohol-free beer enriched with isomaltulose+maltodextrin)

EXPERIMENTAL

This intervention entails the intake of white bread (providing 50 g of carbohydrates) and an alcohol-free beer with modified composition in which the maltose has been almost completely eliminated and enriched with isomaltulose (2.5 g/100 mL) and a resistant maltodextrin (0.8 g/100 mL) (IMB). This beverage included 14.3 g of carbohydrates.

Other: Sub-study 2

Second sub-study: White bread + Alcohol-free beer enriched with ++ maltodextrin

EXPERIMENTAL

This intervention entails the intake of white bread (providing 50 g of carbohydrates) and an alcohol-free beer with modified composition in which the maltose has been almost completely eliminated and enriched a resistant maltodextrin (2.0 g/100 mL) (MB). This beverage included 14.3 g of carbohydrates.

Other: Sub-study 2

Second sub-study: Extra-White bread + Water

ACTIVE COMPARATOR

This intervention entails the intake of white bread which provides 64.3 g (50 g + 14.3 g) of carbohydrates and water. This intervention would be the comparator in carbohydrates-equally conditions.

Other: Sub-study 2

Interventions

Subjects were provided with: a) Glucose beverage; b) Regular alcohol-free beer; c) Alcohol-free beer with modified composition (isomaltulose + maltodextrin); d) Alcohol-free beer with modified composition (++ maltodextrin).

First sub-study: Alcohol-free beer with modified composition (++ maltodextrin)First sub-study: Alcohol-free beer with modified composition (isomaltulose + maltodextrin)First sub-study: Glucose beverageFirst sub-study: Regular alcohol-free beer

Subjects were provided with: a) White bread + Water; b) White bread + Regular alcohol-free beer; c) White bread+Alcohol-free beer enriched with isomaltulose+maltodextrin); d) White bread + Alcohol-free beer enriched with ++ maltodextrin; e) Extra-White bread + Water.

Second sub-study: Extra-White bread + WaterSecond sub-study: White bread + Alcohol-free beer enriched with ++ maltodextrinSecond sub-study: White bread + Regular alcohol-free beerSecond sub-study: White bread + WaterSecond sub-study: White bread+Alcohol-free beer enriched with isomaltulose+maltodextrin)

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • BMI between 18.5 and 27.5 kg/m2.

You may not qualify if:

  • Presence of cardiometabolic pathology such as dyslipemia (total cholesterol \> 200 mg/dL and/or triglycerides \> 150 mg/dL, and/or taking lipid-lowering drugs), prediabetes or type 1 or 2 diabetes mellitus (glucose ≥ 100 mg/dL and/or glycosylated hemoglobin ≥ 5.7% and/or taking hypoglycemic drugs) or high blood pressure without drug treatment.
  • Presence of other chronic pathologies that could interfere with the results of the study such as cardiovascular disease, kidney disease, thyroid disease or liver disease.
  • Presence of intestinal malabsorption syndromes and/or presence of Chron disease or ulcerative colitis.
  • Use of drugs that may interfere with lipid and/or glycidic metabolism.
  • Presence of some analytical alteration that could interfere with the results of the study.
  • Increased or decreased body weight of ≥ 5 kg in the last 6 months.
  • Gluten intolerance.
  • Regular intake of functional foods such as phytosterols or red rice yeast, which have a significant effect on lipid or glycidic metabolism, in the last 6 weeks.
  • Intake of vitamin supplements.
  • Hormone replacement therapy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Instituto de Investigación Sanitaria Aragón, Hospital Universitario Miguel Servet, Universidad de Zaragoza

Zaragoza, 50009, Spain

Location

MeSH Terms

Conditions

Hyperglycemia

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Masking Details
The investigator who prepares the beverages and the bread is not blinded but the investigator who manage the samples and is plan to analyze the results is blinded.
Purpose
PREVENTION
Intervention Model
CROSSOVER
Model Details: The overall study involved two sub-studies. The first one includes 4 arms and the second one includes 5 arms.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD

Study Record Dates

First Submitted

March 2, 2021

First Posted

March 10, 2021

Study Start

February 1, 2020

Primary Completion

December 31, 2020

Study Completion

March 30, 2021

Last Updated

September 30, 2021

Record last verified: 2021-09

Data Sharing

IPD Sharing
Will not share

Locations